AR226212A1 - Procedimiento para preparar nuevos derivados de imidazo rifamicina - Google Patents

Procedimiento para preparar nuevos derivados de imidazo rifamicina

Info

Publication number
AR226212A1
AR226212A1 AR285424A AR28542481A AR226212A1 AR 226212 A1 AR226212 A1 AR 226212A1 AR 285424 A AR285424 A AR 285424A AR 28542481 A AR28542481 A AR 28542481A AR 226212 A1 AR226212 A1 AR 226212A1
Authority
AR
Argentina
Prior art keywords
rifamicina
procedure
prepare new
new imidazo
imidazo derivatives
Prior art date
Application number
AR285424A
Other languages
English (en)
Spanish (es)
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Application granted granted Critical
Publication of AR226212A1 publication Critical patent/AR226212A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AR285424A 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina AR226212A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (1)

Publication Number Publication Date
AR226212A1 true AR226212A1 (es) 1982-06-15

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
AR285424A AR226212A1 (es) 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina

Country Status (25)

Country Link
US (1) US4341785A (OSRAM)
JP (1) JPS5711987A (OSRAM)
AR (1) AR226212A1 (OSRAM)
AT (1) AT373599B (OSRAM)
AU (1) AU537093B2 (OSRAM)
BE (1) BE888895A (OSRAM)
CA (1) CA1142518A (OSRAM)
CH (1) CH648037A5 (OSRAM)
DE (1) DE3120460A1 (OSRAM)
DK (1) DK157876C (OSRAM)
EG (1) EG14891A (OSRAM)
ES (1) ES502906A0 (OSRAM)
FI (1) FI69467C (OSRAM)
FR (1) FR2482967A1 (OSRAM)
GB (1) GB2079270B (OSRAM)
GR (1) GR75640B (OSRAM)
IE (1) IE51204B1 (OSRAM)
IT (1) IT1154655B (OSRAM)
LU (1) LU83376A1 (OSRAM)
NL (1) NL187022C (OSRAM)
NO (1) NO155622C (OSRAM)
PH (2) PH17207A (OSRAM)
PT (1) PT73064B (OSRAM)
SE (1) SE453089B (OSRAM)
ZA (1) ZA813430B (OSRAM)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
TW534813B (en) * 1997-02-28 2003-06-01 Kaneka Corp Treating agent for diseases due to infection with helicobacter
EP1453837A4 (en) * 2001-11-21 2007-11-07 Activbiotics Inc TARGETED THERAPEUTIC AGENTS AND USES THEREOF
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US8758804B2 (en) * 2002-11-05 2014-06-24 Fadim S.R.L. Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
PT1698630E (pt) * 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0614758A2 (pt) 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
CN103263668A (zh) 2006-03-09 2013-08-28 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
DK2054066T3 (en) 2006-08-02 2015-06-08 Salix Pharmaceuticals Inc METHODS OF TREATMENT OF RADIATE ENTERITIS
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
CA2663776C (en) * 2006-09-22 2016-01-26 Cipla Limited Rifaximin in an amorphous form
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
EP2011486B2 (en) 2007-07-06 2015-08-12 Lupin Ltd. Pharmaceutical compositions of rifaximin
WO2009008005A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
CN102015725B (zh) 2008-02-25 2014-10-22 萨利克斯药品有限公司 利福昔明的多种形式及其用途
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
US8309569B2 (en) 2008-02-26 2012-11-13 Salix Pharmaceuticals, Ltd. Methods for treating diarrhea-associated irritable bowel syndrome
PL2294012T3 (pl) 2008-05-07 2014-12-31 Salix Pharmaceuticals Inc Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
PL2327407T3 (pl) 2008-09-26 2014-12-31 Alfasigma Spa Środek profilaktyczny i/lub terapeutyczny na zaburzenia czynnościowe przewodu pokarmowego
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
DK3628319T3 (da) 2008-10-02 2024-03-04 Salix Pharmaceuticals Ltd Behandling af hepatisk encefalopati ved anvendelse af rifaximin
US8916193B2 (en) 2008-12-10 2014-12-23 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
MX2011012829A (es) 2009-06-02 2012-02-28 Salix Pharmaceuticals Ltd Metodos para tratar encefalopatia hepatica.
MX2012002895A (es) 2009-09-13 2012-05-22 Salix Pharmaceuticals Ltd Metodos para tratar el sindrome de intestino irritado (ibs).
RU2012121599A (ru) 2009-10-27 2013-12-10 Люпин Лимитед Твердая дисперсия рифаксимина
MX2012005883A (es) 2009-11-23 2012-10-09 Cipla Ltd Composicion topica en espuma.
EP2401282B2 (en) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
CA2789929C (en) 2010-02-18 2019-11-26 Salix Pharmaceuticals, Ltd. Methods for treating infection
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
JP6092629B2 (ja) 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
ES2801678T3 (es) 2010-07-12 2021-01-12 Salix Pharmaceuticals Inc Formulaciones de rifaximina y sus usos
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
WO2012109605A2 (en) 2011-02-11 2012-08-16 Salix Pharmaceuticals, Ltd. Forms of rifaximin and uses thereof
EP2705042A1 (en) 2011-05-02 2014-03-12 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
WO2013067394A1 (en) 2011-11-02 2013-05-10 Salix Pharmaceuticals, Ltd Methods for treating irritable bowel syndrome (ibs) and infections
WO2013112809A2 (en) 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
KR20150129691A (ko) 2013-03-15 2015-11-20 알파 와셔만 에스.피.아. 질 감염증의 치료에 사용하기 위한 리팍시민
WO2014140995A2 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
JP6433980B2 (ja) 2013-04-12 2018-12-05 アルファシグマ ソシエタ ペル アチオニ Ｎｓａｉｄ投与並びに関連する組成物、方法及びシステム
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
EP3134415A4 (en) * 2014-04-19 2017-10-25 Granules India Limited An improved process for the preparation of rifamycin derivatives
CA2947962C (en) 2014-05-04 2024-01-16 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
EP3546464B1 (en) 2014-05-12 2020-06-17 Alfasigma S.p.A. Preparation and use of crystalline form tau of rifaximin solvated with degme
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
KR20230023043A (ko) 2016-09-30 2023-02-16 샐릭스 파마슈티컬스 인코포레이티드 리팍시민의 고체 분산물 형태
CN110770244A (zh) * 2017-06-26 2020-02-07 倍尔福股份公司 吡啶并咪唑利福霉素衍生物的抗菌剂
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (OSRAM) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
JPS6123192B2 (OSRAM) 1986-06-04
FI811565L (fi) 1981-11-23
NO155622C (no) 1987-04-29
SE453089B (sv) 1988-01-11
FR2482967A1 (fr) 1981-11-27
IE811139L (en) 1981-11-22
FR2482967B1 (OSRAM) 1985-03-29
GR75640B (OSRAM) 1984-08-02
BE888895A (fr) 1981-09-16
ES8203388A1 (es) 1982-04-01
FI69467C (fi) 1986-02-10
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
IT8003429A0 (it) 1980-05-22
NL8102290A (nl) 1981-12-16
PT73064A (en) 1981-06-01
CA1142518A (en) 1983-03-08
FI69467B (fi) 1985-10-31
GB2079270A (en) 1982-01-20
AU7065581A (en) 1981-11-26
NL187022C (nl) 1991-05-01
AT373599B (de) 1984-02-10
PH17207A (en) 1984-06-19
IT1154655B (it) 1987-01-21
ATA222781A (de) 1983-06-15
DK224781A (da) 1981-11-23
DK157876B (da) 1990-02-26
GB2079270B (en) 1984-01-18
DE3120460A1 (de) 1982-03-11
IE51204B1 (en) 1986-10-29
DK157876C (da) 1990-07-30
LU83376A1 (fr) 1981-09-11
NO811731L (no) 1981-11-23
AU537093B2 (en) 1984-06-07
NL187022B (nl) 1990-12-03
DE3120460C2 (OSRAM) 1990-12-13
CH648037A5 (de) 1985-02-28
JPS5711987A (en) 1982-01-21
ZA813430B (en) 1982-06-30
EG14891A (en) 1985-12-31
PH18704A (en) 1985-09-05
NO155622B (no) 1987-01-19
ES502906A0 (es) 1982-04-01
US4341785A (en) 1982-07-27

Similar Documents

Publication Publication Date Title
AR226212A1 (es) Procedimiento para preparar nuevos derivados de imidazo rifamicina
MX7035E (es) Procedimiento para preparar 3-isoxazolidinona
ES498395A0 (es) Procedimiento para preparar derivados de la eritromicina
MX155025A (es) Procedimiento para producir cefalosporinas
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
AR230995A1 (es) Procedimiento para producir n-fosfono-metilglicina
ES550241A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES504218A0 (es) Procedimiento para preparar derivados de amidas.
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
ES550240A0 (es) Procedimiento para preparar nuevos derivados imidazo
AR240816A1 (es) Procedimiento para producir nuevos derivados de la cumarina
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES518189A0 (es) Procedimiento para preparar nuevos derivados de encefalina.
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
ES500455A0 (es) Procedimiento para la preparacion de nuevos derivados de urea
ES549804A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES511058A0 (es) Procedimiento para preparar nuevos derivados de fenoxibencilo.
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
ES502649A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
ES557313A0 (es) Procedimiento para preparar derivados de fenilpirazina
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina